estrone-3-glucuronide has been researched along with goserelin in 2 studies
Studies (estrone-3-glucuronide) | Trials (estrone-3-glucuronide) | Recent Studies (post-2010) (estrone-3-glucuronide) | Studies (goserelin) | Trials (goserelin) | Recent Studies (post-2010) (goserelin) |
---|---|---|---|---|---|
191 | 18 | 21 | 1,657 | 557 | 327 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baird, DT; West, CP | 1 |
Forti, G; Magini, A; Massi, GB; Pellegrini, S; Serio, M; Tavella, K | 1 |
1 trial(s) available for estrone-3-glucuronide and goserelin
Article | Year |
---|---|
Estrogenic suppression by different administration schedules of goserelin depot for treatment of endometriosis.
Topics: Adult; Delayed-Action Preparations; Endometriosis; Estrogen Antagonists; Estrone; Female; Follicular Phase; Goserelin; Humans; Laparoscopy; Luteal Phase; Luteinizing Hormone; Ovarian Function Tests; Pregnanediol | 1993 |
1 other study(ies) available for estrone-3-glucuronide and goserelin
Article | Year |
---|---|
Suppression of ovarian activity by Zoladex depot (ICI 118630), a long-acting luteinizing hormone releasing hormone agonist analogue.
Topics: Adult; Buserelin; Creatinine; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Ovary; Pregnanediol; Progesterone | 1987 |